Efficacy of liraglutide as a follow-up therapy after resolution of glucotoxicity with intensive insulin therapy

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 4, 2013, Pages 223-225

  Arakawa, Masayuki ^a   Ebato, Chie ^b  

^a Yashio Central General Hospital   (Japan)

^b Higashi Toride Hospital   (Japan)

Author keywords

Diabetes mellitus; GLP 1 receptor agonist; Hypoglycemia; Intensive insulin therapy; Liraglutide

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIRAGLUTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; MALE; MAXIMUM PERMISSIBLE DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES MELLITUS; GLP-1 RECEPTOR AGONIST; HYPOGLYCEMIA; INTENSIVE INSULIN THERAPY; LIRAGLUTIDE;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; MALE; MIDDLE AGED; RECEPTORS, GLUCAGON; TREATMENT OUTCOME;

EID: 84889079607     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.10.002     Document Type: Article

References (13)

1. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, and M. Nauck Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 35 2012 1364 1379
2. M.F. Pollack, F.W. Purayidathil, S.C. Bolge, and S.A. Williams Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life Diabetes Res Clin Pract 87 2010 204 210
3. A.D. Rao, N. Kuhadiya, K. Reynolds, and V.A. Fonseca Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational studies Diabetes Care 31 2008 1672 1678
4. Y. Li, W. Xu, Z. Liao, B. Yao, X. Chen, and Z. Huang Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function Diabetes Care 27 2004 2597 2602 (Pubitemid 39441457)
5. E.A. Ryan, S. Imes, and C. Wallace Short-term intensive insulin therapy in newly diagnosed type 2 diabetes Diabetes Care 27 2004 1028 1032 (Pubitemid 38579760)
6. J.J. Holst The physiology of glucagon-like peptide 1 Physiol Rev 87 2007 1409 1439 (Pubitemid 350041474)
7. M.A. Nauck Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications Am J Med 124 2011 S3 S18
8. A. Kashiwagi, M. Kasuga, E. Araki, Y. Oka, T. Hanafusa, and H. Ito International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values J Diabetes Invest 3 2012 39 40
9. R. Retnakaran, and D.J. Drucker Intensive insulin therapy in newly diagnosed type 2 diabetes Lancet 371 2008 1725 1726 (Pubitemid 351697932)
10. G. Xu, H. Kaneto, D.R. Laybutt, V.F. Duvivier-Kali, N. Trivedi, and K. Suzuma Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes Diabetes 56 2007 1551 1558 (Pubitemid 46842610)
11. P.V. Højberg, T. Vilsbøll, R. Rabøl, F.K. Knop, M. Bache, and T. Krarup Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes Diabetologia 52 2009 199 207
12. P.V. Højberg, M. Zander, T. Vilsbøll, F.K. Knop, T. Krarup, and A. Vølund Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes Diabetologia 51 2008 632 640
13. K. Iizuka, R. Tomita, T. Suwa, Y. Horikawa, and J. Takeda Normalization of fasting hyperglycemia is beneficial for successful introduction of small amount of the GLP-1 analog liraglutide in an obese patient with type 2 diabetes mellitus Diabetol Int 3 2012 61 64